Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
HDFC Pharma and Healthcare Fund - Growth Option
HDFC Mutual Fund · Equity · Sectoral/ Thematic
₹21.97
AUM: —
NAV updated 18 days ago
Option
Growth
Risk
Very High
Sharpe Ratio
2.16
Std Dev (1Y)
12.83%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
+2.42%
3m
+11.9%
6m
+26.44%
1y
+26.77%
3y
—
5y
—
10y
—
since inception
+30.95%
TopFund's Take on HDFC Pharma and Healthcare Fund - Growth Option
HDFC Pharma and Healthcare Fund - Growth Option is a Sectoral/ Thematic fund from HDFC Mutual Fund.
Cost: Expense ratio data for this fund isn't available yet.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a strong Sharpe ratio of 2.16 — the fund has generated solid returns relative to the volatility it exposed investors to. Separately, annualised volatility of 12.83% is fairly typical for Sectoral/ Thematic funds.
Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
Sector Allocation
Sector allocation not available yet.
Asset Allocation
Asset allocation not available yet.
Fund Snapshot
Tools & Guides for This Fund
Frequently Asked Questions about HDFC Pharma and Healthcare Fund - Growth Option
The current NAV (Net Asset Value) of HDFC Pharma and Healthcare Fund - Growth Option is ₹21.97. NAV is updated every business day after market close by AMFI.
1Y: 26.77%
Expense ratio data for HDFC Pharma and Healthcare Fund - Growth Option is not yet available.
HDFC Pharma and Healthcare Fund - Growth Option is managed by HDFC Mutual Fund.
HDFC Pharma and Healthcare Fund - Growth Option is classified as a Very High risk fund. It is suitable for aggressive investors with a long-term horizon of 5+ years.
HDFC Pharma and Healthcare Fund - Growth Option is a Sectoral/ Thematic fund. SIP suitability depends on your investment goal and risk profile.
You can start a SIP in HDFC Pharma and Healthcare Fund - Growth Option with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.